Increased FGF-23 levels are linked to ineffective erythropoiesis and impaired bone mineralization in myelodysplastic syndromes.
Weidner H, Baschant U, Lademann F, Ledesma Colunga MG, Balaian E, Hofbauer C, Misof BM, Roschger P, Blouin S, Richards WG, Platzbecker U, Hofbauer LC, Rauner M.
Weidner H, et al. Among authors: misof bm.
JCI Insight. 2020 Aug 6;5(15):e137062. doi: 10.1172/jci.insight.137062.
JCI Insight. 2020.
PMID: 32759495
Free PMC article.